Does HRT Cause Cancer? Understanding the Risks of Hormone Therapy

Key Takeaways:

• For most people, hormone replacement therapy (HRT) does not cause cancer and is safe when used appropriately.

• People who start HRT before age 60 or within 10 years of menopause usually see the greatest benefits.

• Some forms of HRT may slightly increase the risk of certain types of cancers, such as breast or uterine cancer, depending on the type, dose, and duration of therapy.

• A healthcare provider can help you weigh potential benefits against individual risk factors to help you decide whether HRT is right for you.
  

Hormone replacement therapy (HRT) can be highly effective for managing menopause symptoms, but the decision to start treatment is a big one. It’s normal to feel concern about how HRT might affect your risk of cancer.

Having clear, factual information and guidance that acknowledges your concerns can make navigating such decisions less daunting and scary. This guide provides information on the relationship between HRT and cancer, which you can use to make informed, confident decisions about your health.

Reproductive hormones like estrogen and progesterone play vital roles in nearly every part of the body. When hormone levels drop during perimenopause and menopause, it’s common to experience a variety of symptoms. HRT therapy can help provide relief. 

HRT, sometimes called menopause hormone therapy, comes in several forms, including pills, patches, gels, and sprays.

Types of HRT

While there are many ways to take HRT, there are only a few overall therapeutic approaches. These include:  

• Combined estrogen and progesterone systemic therapy: Intended for women with a uterus, progesterone helps protect the uterine lining from the effects of estrogen therapy. The two hormones generally have separate administrations (though combination options exist) and are available in patches, pills, sprays, and gels.  

• Low-dose vaginal estrogen: This therapy is used to treat symptoms localized to the vaginal and urinary systems. Usually a vaginal cream or suppository, this treatment doesn’t typically relieve full-body symptoms like hot flashes or night sweats. 

• Estrogen-only systemic therapy: Typically intended for those without a uterus, this therapy is available in a number of forms. 

HRT Benefits

HRT can provide profound benefits, including:

• Relief from symptoms of menopause, like hot flashes, night sweats, and disturbed sleep

• Reduced vaginal dryness and discomfort during sex

• Prevention of osteoporosis and reduced risk of fractures

• Improvements in mood and overall quality of life

Hormone replacement therapy (HRT) for menopause symptoms is generally safe and comes with a low risk of cancer for most people. 

But for some people, HRT may pose an increased risk of cancer. The cancer risks associated with HRT depend on your medical history and the form of treatment you’re considering. That’s why personalized guidance from a healthcare provider is essential.

“Hormone therapy is never one-size-fits-all,” says Lynn Marie Morski, MD, JD. “Weighing the potential benefits against the risks requires an individualized discussion, and working closely with a knowledgeable provider helps identify the safest and most effective approach for each patient.”

Several factors influence whether therapy may increase, decrease, or have no effect on cancer risk. These include:

1. Type of HRT

2. Timing of treatment 

3. Duration of treatment

4. Individual health profile

1. Type of Hormone Replacement Therapy (HRT) and Cancer Risk

The main hormones used for HRT are estrogen and progestin (a synthetic form of progesterone). How they’re combined — or not — affects cancer risk differently.

Estrogen-Alone HRT and Cancer Risk

Providers often prescribe estrogen alone to patients who’ve had a hysterectomy. Here’s how this form of HRT may influence cancer risk:

• Breast cancer and estrogen-only HRT. Clinical trials from the Women's Health Initiative (WHI) have found that estrogen-only therapy in women without a uterus doesn’t appear to increase the risk of breast cancer. More recent studies have found associations between this form of HRT and a reduced risk of breast cancer, especially in women who are in the postmenopause phase of life.

• Endometrial cancer and estrogen-only HRT. Estrogen therapy without progestin in women with a uterus can increase the risk of endometrial cancer. This isn’t the case for women who’ve had a hysterectomy.

• Ovarian cancer and estrogen-only HRT. The data here is mixed. Some small studies suggest a small potential increase in ovarian cancer risk with long-term use (more than five to 10 years) of estrogen-only therapy, while others don’t show a significant link, but do note that the risk, especially in long-term users, is slightly higher. Research is ongoing, and you should discuss the risks with your doctor, especially if you have a family history of ovarian cancer.

Combined Estrogen-Progestin HRT and Cancer Risk

For women with a uterus, estrogen is usually paired with progestin to protect the uterine lining. This combination therapy has a slightly different risk profile than estrogen alone.

Large studies, including the Women’s Health Initiative trial, suggest a link between combined therapy and a small but measurable increase in breast cancer risk, especially with longer-term use. On the other hand, adding progestin largely eliminates the endometrial cancer risk seen with estrogen-only therapy.

Interestingly, some research has also found a reduced risk of colorectal cancer in women using combined therapy, though this isn’t a primary reason for prescribing the form of HRT.

Low-Dose Vaginal Estrogen and Cancer Risk

According to research, low-dose vaginal estrogen is generally lower-risk than systemic options like estrogen-progestin pills. Even for women with a history of gynecologic cancer, it’s considered safe to use.

That’s because pills, patches, and gels circulate hormones throughout your entire body, while localized vaginal treatments mainly act on nearby tissues with minimal absorption into the bloodstream.

2. HRT Timing and Cancer Risk

The timing of when you start hormone therapy can make a big difference. Here’s what the research suggests:

• Starting early: If you begin HRT earlier (ideally within about 10 years of your last period or before age 60), the benefits tend to outweigh the risks. This is sometimes called the “window of opportunity.” Starting during this stage is linked with better relief of symptoms and a lower chance of complications.

• Starting late: Beginning therapy well after menopause may raise the risks of certain conditions, like breast cancer or heart disease, especially with combined estrogen–progestin treatment.

3. Duration of HRT Use

How long you stay on HRT might influence risk, too. Here’s a look at the impact of that duration for estrogen-only and combined HRT, according to research:

• Estrogen-only therapy: In women without a uterus, breast cancer risk doesn’t increase, even with longer use. HRT may even decrease breast cancer risk.

• Combined estrogen-progestin therapy:  Here, the slight increased risk of breast cancer typically appears after three to five years of continuous use and rises with longer durations.

4. Personal Medical History

Your medical history is another key piece of information. Some factors that can put you at a higher risk or at least impact your eligibly for HRT include:

• Personal or family history of hormone-sensitive cancers (breast, endometrial, and ovarian cancer)

• A history of blood clots, heart disease, or other cardiovascular issues

It’s common to worry about whether HRT could cause cancer. The good news? For most women, hormone replacement therapy is safe and effective for managing moderate to severe symptoms of menopause, particularly when starting HRT before age 60 or within 10 years of the onset of menopause.

Here’s what to keep in mind:

• Cancer risks are generally small. While some forms of HRT are linked to slightly higher risks for certain cancers, such as breast or uterine cancer, the increases are typically small.

• Type, dose, timing, and personal factors matter. Estrogen-only HRT (for those without a uterus) and combined estrogen-progestin therapy carry different cancer risk profiles. Starting HRT closer to the onset of menopause and using the lowest effective dose for the shortest necessary duration generally minimizes risk.

• Ongoing monitoring is key. Regular check-ins with your healthcare provider — including mammograms, pelvic exams, and discussions of symptoms — help ensure your therapy remains safe and effective.

The decision to start HRT is deeply personal, and understanding the nuances of cancer risk helps you engage in informed, meaningful discussions with your healthcare provider.

Does transdermal hormone replacement therapy cause cancer?

Research suggests that when used appropriately, transdermal forms of HRT don’t increase breast or endometrial cancer risk any more than other systemic forms. You apply transdermal HRT patches, gels, or sprays to the skin, as opposed to taking them orally. With transdermal absorption, hormones enter the bloodstream without first passing through the liver, which may carry a slightly lower risk of certain complications, like blood clots. 

Do bioidentical hormones cause cancer?

Bioidentical hormones like estradiol and micronized progesterone — which are chemically identical to the estrogen and progesterone your body naturally produces — may have a more favorable safety profile than conventional HRT. While some studies suggest bioidentical hormones carry a lower risk of certain cancers, for example, micronized progesterone has a lower risk of breast cancer when used in HRT than synthetic progestin.

What are the chances of getting cancer from HRT?

The risk of cancer from hormone replacement therapy (HRT) is relatively low and depends on several factors, including the type of HRT in question, when you start it, how long you use it, and your personal medical history. Discuss with your healthcare provider if it is the best treatment for you.

Is hormone therapy the same as hormone replacement therapy?

No. Hormone therapy for cancer treatment is different than hormone replacement therapy for menopause. For the former, hormones are not being replaced, but are targeting specific cancers. Specifically, for people with hormone-receptor-positive breast cancer, hormone therapy is a cornerstone of treatment that significantly reduces the risk of breast cancer recurrence and improves survival rates.

Can cancer survivors and cancer patients use HRT for menopause?

Research generally does not support people with a history of hormone-sensitive cancers using HRT. However, every person’s situation is different. In some cases, localized low-dose therapies (like vaginal estrogen) may be considered. It’s best to work closely with an oncologist or menopause specialist to chart the best path for your needs..

Are there other ways to manage symptoms of menopause besides HRT?

Absolutely. If HRT isn’t a good fit for you — or if you prefer a non-hormonal approach — there are several options to consider. One is non-hormonal medications. SSRI (selective serotonin reuptake inhibitors) or SNRI (serotonin–norepinephrine reuptake inhibitors) antidepressants can help with hot flashes and mood changes. Drugs such as gabapentin or clonidine may reduce night sweats. Lifestyle factors, like nutrition, sleep, exercise, and stress also play a role in balancing hormones.

What’s the safest way to do HRT?

If you decide to proceed with hormone therapy, it’s necessary that you commit to regular checkups, cancer screenings, and tracking of symptoms and side effects. Honest, ongoing conversations with your provider are essential for maximizing benefits while minimizing risks, and ensuring HRT is as safe and effective as possible for your individual needs.